Telitacicept
Product Specifications
CAS Number
2136630-26-5
Target
TNF
Related Pathways
Apoptosis
Bioactivity
Telitacicept (RC18), a fully human TACI-Fc fusion protein, acts as a dual inhibitor of B lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand), effectively impeding B lymphocyte proliferation. This compound is applicable in researching B-cell autoimmune diseases [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1009309-01 0.02 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Ubiquitin-conjugating enzyme E2 2 (RAD6)
Sign In for Pricing
View Details MBS1009309-02 0.1 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Ubiquitin-conjugating enzyme E2 2 (RAD6)
Sign In for Pricing
View Details MBS1009309-03 0.02 mg (Yeast)
Recombinant Saccharomyces cerevisiae Ubiquitin-conjugating enzyme E2 2 (RAD6)
Sign In for Pricing
View Details